Tag Archives: investors

Picks and Pans – The Buy-Side View for 2012

Survey

What’s the forecast for biotech in 2012? Do investors think it is a good time to invest in biotechnology? Are they interested in taking on early stage companies? At the BIO CEO & Investor Conference opening plenary, the BIO Industry Analysis team released results from their Investor Perception Study and, afterwards, a panel of portfolio managers and senior buy-side analysts fielded a range of question about the challenges and opportunities facing the industry. David Gluckman, M.D., Read More >

Events  |  1 Comment  |  Email This Post
Tags: , , , , ,

A Very Big BTK January

BTK-Jan-1992-2012-115x76

We all heard reports that January was a great start to 2012 for the stock market, and even more so for Biotech. But how big was it, really? The Amex Biotech Index (the “BTK“) had its biggest January on record, since 1992, with a +21% pop: The companies behind the numbers? The Nasdaq Biotech Index was up 11%, the best in a decade. The January 2000 jump of 15% is still a tough month to beat Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , ,

Big Changes for 1×1 Partnering – Investor Profiles

As BIO CEO approaches (February 14-15, 2011!), the BIO Partnering Team is proud to present several improvements to the 1×1 Partnering System. One of the most noticeable changes so far is the new investor profile, now bigger and better than ever. The new profile not only increases the information investors input into the system, but it also helps biotech companies gain more value from the conference overall. The Search function is one we’ve continuously updated Read More >

The One-on-One Compass  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Investor Perception Study Predicts Future of Biotech Sector

The BIO/Thomson Reuters Investor Perception Study is an in-depth assessment of Wall Street’s views of the biotech industry, its current challenges, its relative valuation, and the outlook for 2009. The analysis aims to provide BIO members with an insider’s perspective on what the investment community values in the current economic climate and help foster more effective communication between company management, shareholders, and potential investors.

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , , ,